Helle Charlotte Thiesson

Helle Charlotte Thiesson is a Clinical Lecturer at the Department of Clinical Research within the Faculty of Health Sciences at the University of Southern Denmark, with dual affiliations at Odense University Hospital (OUH) and Karolinska Institutet (KI). Her primary research activities occur in the Research Unit of Nephrology (Odense).

Her research interests focus on:

• Kidney Transplantation
• Nephrology
• Chronic Kidney Disease
• Clinical Pharmacology
• Transplant Immunology
• Pharmacokinetics of Immunosuppressants

Recent publications (2024-2025) demonstrate concentrated work on immunosuppressant drug monitoring in kidney transplantation, particularly tacrolimus and mycophenolic acid dosing strategies. She investigates posttransplant lymphoproliferative disease (PTLD) risk in Epstein-Barr virus seronegative recipients through multi-center Nordic cohort studies and examines coagulation mechanisms (kallikrein, Factor XII) in chronic kidney disease and hemodialysis.

Thiesson has supervised two students, as noted in her profile. Her academic engagement includes participation in major transplant conferences such as ESOT Congress (2019, 2021), ERA-EDTA Congress (2020, 2021), and NSN (2019), reflecting active community involvement.

She operates within the Research Unit of Nephrology at Odense University Hospital, collaborating closely with the Department of Clinical Research at the University of Southern Denmark on clinical studies in transplantation and renal disease.